Effect of sodium-glucose cotransporter 2 inhibitors on ventricular function in systemic right ventricular failure

Effect of sodium-glucose cotransporter 2 inhibitors on ventricular function in systemic right ventricular failure

Background Systemic right ventricle (sRV) patients are at an increased risk of developing heart failure. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) could be a valuable treatment option. This study investigated the changes in ventricular function in sRV failure patients in the first year afte...

Full description

Saved in:
Bibliographic Details
Main Authors: Lorna Swan, Gruschen R Veldtman, Hubert W Vliegen, Philippine Kiès, Filip Zemrak, Amanda Hunter, Anastasia D Egorova, Monique RM Jongbloed, J Wouter Jukema, Simon T MacDonald, Niki L Walker, Ali N Zaidi, Madelien V Regeer, Bart JA Mertens, Ralph ML Neijenhuis, Ari M Cedars
Format: Article
Language:English
Published: BMJ Publishing Group 2025-07-01
Series:Open Heart
Online Access:https://openheart.bmj.com/content/12/2/e003445.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://openheart.bmj.com/content/12/2/e003445.full

Similar Items